Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine

被引:363
作者
Choi, JS
Nam, K
Park, J
Kim, JB
Lee, JK
Park, J
机构
[1] Seoul Natl Univ, Sch Chem & Mol Engn, Seoul 151742, South Korea
[2] Chungnam Natl Univ, Dept Biochem, Taejon 305764, South Korea
[3] Inha Univ, Dept Anat, Sch Med, Inchon, South Korea
基金
新加坡国家研究基金会;
关键词
dendrimer; L-arginine; plasmid DNA; polyplex; gene delivery;
D O I
10.1016/j.jconrel.2004.07.027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We designed a novel type of arginine-rich dendrimer, with a structure based on the well-defined dendrimer, polyamidoamine dendrimer (PAMAM). Further characterization was performed to prove that the polymer is a potent nonviral gene delivery carrier. The primary amines located on the surface of PAMAM were conjugated with L-arginine to generate an L-argininegrafted-PAMAM dendrimer (PAMAM-Arg). For comparison, an L-lysiiie-grafted-PAMAM dendrimer (PAMAM-Lys) was also generated and compared as a control reagent. The polymers were found to self-assemble electrostatically with plasmid DNA, forming nanometer-scale complexes. From dynamic light scattering experiments, the mean diameter of the polyplexes was observed to be around 200 nm. We used PicoGreen reagent as an efficient probe for assaying complex formation of polymers with plasmid DNA. The complex composed of PAMAM-Arg/DNA showed increased gene delivery potency compared to native PAMAM dendrimer and PAMAM-Lys. The cytotoxicity and transfection efficiencies for 293, HepG2, and Neuro, 2A cells were measured by comparison with PEI and PAMAM. In addition, transfection experiments were performed in primary rat vascular smooth muscle cells, and PAMAM-Arg showed much enhanced transfection efficiency. These findings suggest that the L-arginine-grafted-PAMAM dendrimer possesses the potential to be a novel gene delivery carrier for gene therapy. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:445 / 456
页数:12
相关论文
共 32 条
[21]   Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro [J].
Okuda, T ;
Sugiyama, A ;
Niidome, T ;
Aoyagi, H .
BIOMATERIALS, 2004, 25 (03) :537-544
[22]   Key issues in non-viral gene delivery (Reprinted from Advanced Drug Delivery Reviews, vol 34, pg 3-19, 1998) [J].
Pouton, CW ;
Seymour, LW .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :187-203
[23]   Gene transfer with lipospermines and polyethylenimines [J].
Remy, JS ;
Abdallah, B ;
Zanta, MA ;
Boussif, O ;
Behr, JP ;
Demeneix, B .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 30 (1-3) :85-95
[24]   Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells [J].
Rudolph, C ;
Plank, C ;
Lausier, J ;
Schillinger, U ;
Müller, RH ;
Rosenecker, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11411-11418
[25]   Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide - Role for cell-surface proteoglycans [J].
Sandgren, S ;
Cheng, F ;
Belting, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38877-38883
[26]   Non-viral and hybrid vectors in human gene therapy: an update [J].
Schmidt-Wolf, GD ;
Schmidt-Wolf, IGH .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (02) :67-72
[27]  
Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO
[28]  
2-P
[29]   Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes [J].
Torchilin, VP ;
Levchenko, TS ;
Rammohan, R ;
Volodina, N ;
Papahadjopoulos-Sternberg, B ;
D'Souza, GGM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1972-1977
[30]   TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors [J].
Torchilin, VP ;
Rammohan, R ;
Weissig, V ;
Levchenko, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8786-8791